Physician profile
Richard Paul Bransford
NPI 1851351241
$1,645.12
in general payments reported to CMS, 2019-2025
12 companies · $1,390 in 2025
The $1,390 reported for 2025 was less than what a typical Clinical & Laboratory Immunology (Allergy & Immunology) provider received nationally (typical 2025 total: $1,390).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.60 · 2020: $14.86 · 2021: $70.29 · 2022: $79.28 · 2024: $64.13 · 2025: $1,390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $793 · Food and Beverage: $662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $792.51 |
| Food and Beverage | $661.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Icotec Medical INC. | $1,389.96 | 2025 | |
| Depuy Synthes Sales INC. | $64.13 | 2024 | Teligen |
| Optinose US, INC. | $31.25 | 2021 | |
| Glaxosmithkline, LLC. | $27.98 | 2022 | |
| Genzyme Corporation | $26.60 | 2019 | |
| Aimmune Therapeutics, INC. | $26.05 | 2020-2021 | |
| Astrazeneca Pharmaceuticals Lp | $15.17 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.19 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.75 | 2022 | |
| Pharming Healthcare, INC. | $12.72 | 2022 | |
| Pfizer INC. | $12.68 | 2021 | |
| Biocryst US Sales Co., LLC | $12.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Bransford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.